Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient

Neurology

Volumn 59, Issue 7, 2002, Pages 1102-1104

  Ihara, M ^a   Kohara, N ^a   Urano, F ^a   Ichinose, H ^a   Takao, S ^a   Nishida, T ^a   Saiki, H ^a   Kawamoto, Y ^a   Ikeda, A ^a   Takagi, S ^a   Shibasaki, H ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; DANTROLENE; DIAZEPAM; DOPA; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CATATONIA; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; DOPAMINERGIC SYSTEM; DYSKINESIA; DYSTONIA; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MUSCLE HYPERTONIA; NEUROLEPTIC MALIGNANT SYNDROME; NIGRONEOSTRIATAL SYSTEM; PRIORITY JOURNAL; PSYCHOSIS; TREATMENT OUTCOME;

EID: 0037044238     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.7.1102     Document Type: Article

References (10)

1. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994;8:236-242.
2. Gurrera RJ. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome. Am J Psychiatry 1999;156:169-180.
3. Bandmann O, Nygaard TG, Surtees R, Marsden CD, Wood NW, Harding AE. Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 1996;5:403-406.
4. Fink JK, Barton N, Cohen W, Lovenberg W, Burns RS, Hallett M. Dystonia with marked diurnal variation associated with biopterin deficiency. Neurology 1988;38:707-711.
5. Fink M. Neuroleptic malignant syndrome and catatonia: one entity or two? Biol Psychiatry 1996;39:1-4.
6. Fleischhacker WW, Levine RA, Lieberman JA, Pollack S, Johns CA, Richardson MA. Neopterin and biopterin CSF levels in tardive dyskinesia after clozapine treatment. Biol Psychiatry 1993;34:741-745.
7. de la Fuente-Fernández R. Tardive dyskinesia in dopa-responsive dystonia: a reappraisal of the dopamine hypothesis of tardive dyskinesia. Neurology 1998;50:1134-1135.
8. Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 1991;41:174-181.
9. Segawa M. Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev 2000;22(suppl 1):S65-S80.
10. Ueda M, Hamamoto M, Nagayama H, et al. Susceptibility to neuroleptic malignant syndrome in Parkinson's disease. Neurology 1999;52:777-781.